Sophia Genetics SA (SOPH) — Long-term Investment Intensity
Sophia Genetics SA (SOPH) has a Long-term Investment Intensity of 0.6% as of December 2020. Long-term investments of $775.00K represent 0.6% of total assets of $132.12 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore cash efficiency ratio of Sophia Genetics SA to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Sophia Genetics SA Long-term Investment Intensity (2018–2020)
This chart shows how Sophia Genetics SA's Long-term Investment Intensity has evolved across 3 annual periods from 2018 to 2020. As of December 2020, the intensity stands at 0.6%, reflecting long-term investments of $775.00K against total assets of $132.12 Million USD. Explore Sophia Genetics SA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Sophia Genetics SA (2018–2020)
The table below presents the year-by-year Long-term Investment Intensity for Sophia Genetics SA from 2018 to 2020, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Sophia Genetics SA market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2020 | 0.6% | $775.00K | $132.12 Million | ▼ -0.1 pp |
| 2019 | 0.7% | $373.00K | $51.66 Million | ▲ +0.4 pp |
| 2018 | 0.3% | $260.00K | $76.62 Million | — |